- Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis
-
Chen J, Tian CX, Yu M, Lv Q, Cheng NS, Wang Z, Wu X
- KMID: 2353085
- J Breast Cancer.
- 2014 Mar;17(1):61-68.
PURPOSE: The aim of the study was to evaluate the efficacy and safety of combining sorafenib with chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-negative advanced breast... -
- CITED
-
- Close
- SHARE
-
- Close
